These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 796526)

  • 81. [Evaluation of anginine in the treatment of cerebrovascular disorders (preliminary report)].
    Majkowski J
    Neurol Neurochir Pol; 1975; 9(3):381-8. PubMed ID: 1153068
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Diabetes in patients with vascular diseases].
    Plauchu M; Pousset G
    J Med Lyon; 1972 Jan; 53(220):31-40. PubMed ID: 5039268
    [No Abstract]   [Full Text] [Related]  

  • 83. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
    Diamantopoulos EJ; Grigoriadou M; Ifanti G; Raptis SA
    Int Angiol; 2001 Dec; 20(4):337-44. PubMed ID: 11782701
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Role of physiologically active substances in the pathogenesis and therapy of atherosclerosis].
    Klimov AN
    Vestn Akad Med Nauk SSSR; 1976; (9):48-50. PubMed ID: 1020445
    [No Abstract]   [Full Text] [Related]  

  • 85. [Diabetic microangiopathies].
    Standl E
    Internist (Berl); 1987 Apr; 28(4):262-72. PubMed ID: 3298125
    [No Abstract]   [Full Text] [Related]  

  • 86. [Prodectin in the treatment of viral hepatitis].
    Kozhukhova EA; Iakushin AI; Zakharova VI; Mebel' BD; Larionov GM
    Sov Med; 1983; (10):96-7. PubMed ID: 6658556
    [No Abstract]   [Full Text] [Related]  

  • 87. [Mechanism of action and clinical effectiveness of the new Soviet-made drug parmidin in the treatment of arteriosclerosis and ischemic heart disease].
    Kukes VG; Mashkovskiĭ MD; Paskhina TS; Borisov VG; Shvarts GIa
    Kardiologiia; 1978 Oct; 18(10):61-8. PubMed ID: 213636
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Treatment of atherosclerosis obliterans with pyridinolcarbamate.
    Atsumi T; Motomiya T; Isokane N; Shimamoto T
    Jpn Heart J; 1971 Jul; 12(4):335-46. PubMed ID: 5314713
    [No Abstract]   [Full Text] [Related]  

  • 89. [Prodectin treatment of partial hearing loss as a result of atherosclerosis].
    Smirnova NA; Timakov VA; Mikushkin MK
    Vestn Otorinolaringol; 1982; (6):53-6. PubMed ID: 7179649
    [No Abstract]   [Full Text] [Related]  

  • 90. [Effect of parmidin on the course of tuberculosis under isoniazid therapy].
    Solov'eva IP; Makinskiĭ AI
    Vrach Delo; 1984 Sep; (9):70-3. PubMed ID: 6390963
    [No Abstract]   [Full Text] [Related]  

  • 91. Iloprost and peripheral arterial disease in diabetic patients.
    Vicari AM; Chiesa R; Mari G; Galimberti M; Di Carlo V; Pozza G
    Acta Diabetol Lat; 1991; 28(1):113-4. PubMed ID: 1713729
    [No Abstract]   [Full Text] [Related]  

  • 92. [Clinical results of the use of carbonyl-3-pyridine citrate (euclidin) during arterial disease].
    Berthier G; Berthier JP
    Sem Ther; 1965 May; 41(5):311-3. PubMed ID: 5878952
    [No Abstract]   [Full Text] [Related]  

  • 93. Leg cramps in geriatric diabetics with peripheral vascular ischemia: treatment.
    Stern FH
    J Am Geriatr Soc; 1966 Jun; 14(6):609-16. PubMed ID: 5327768
    [No Abstract]   [Full Text] [Related]  

  • 94. Sulfonylureas and platelet function.
    Blumenthal SA
    Am J Med; 1983 May; 74(5):795-6. PubMed ID: 6404166
    [No Abstract]   [Full Text] [Related]  

  • 95. [Efficacy and safety of glycine and limontar in the complex therapy of discirculatory encephalopathy and encephalopathy in diabetes mellitus type I].
    Chuĭko MR; Efremova NM; Skvortsova VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(6):44-8. PubMed ID: 20559273
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Inhibition of capillary permeability by a combination of pyridinolcarbamate and adenosine].
    Igual A; Vericat Cadesas F; Beaus R
    Arch Farmacol Toxicol; 1978 Apr; 4(1):88-9. PubMed ID: 697407
    [No Abstract]   [Full Text] [Related]  

  • 97. [Anginin effect in cerebovascular disorders in the light of psychological studies].
    Michalska I
    Neurol Neurochir Pol; 1979; 13(2):141-6. PubMed ID: 377119
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Acute hepatitis due to pyricarbate (Angioxine). Apropos of 5 cases].
    Biour M; Barbare JC; Begaud B; Furet Y; Grange JD; Cheymol G
    Therapie; 1984; 39(5):531-6. PubMed ID: 6506010
    [No Abstract]   [Full Text] [Related]  

  • 99. [Biopharmaceutical studies on pyridinolcarbamate. I. Effect of continuous pyridinolcarbamate administration on renal excretion of sulfonamides in rabbits (author's transl)].
    Ichibagase H; Imamura Y; Suenaga A; Kawabata H
    Yakugaku Zasshi; 1978 Nov; 98(10):1398-402. PubMed ID: 745048
    [No Abstract]   [Full Text] [Related]  

  • 100. [Contribution to therapy of vascular insufficiency by sulfonylurea (Bucarban)].
    HERMANN B; PLUHAR J
    Z Gesamte Inn Med; 1962 Nov; 17():980-3. PubMed ID: 13961104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.